Abstract

Introduction: Adenosquamous carcinoma (ASC) of the head and neck is a rare malignant tumor, with one hundred cases diagnosed so far in the literature. Observation: A 66 years old female patient had a ASC of the right posterior floor of the mouth with a classification T1N0M0. Treatment consisted of surgical management and active surveillance. Discussion: Through this case report, we present this type of tumor and we discuss the main differential diagnosis from a clinical and histological point of view. Conclusion: This entity was described for the first time in 1968 by Gerughty. The CAS is defined by the World Health Organization as “a tumor of the upper respiratory tract, with two distinct squamous and glandular components.” The CAS is considered as an aggressive tumor with a redoubtable prognosis should not be ignored.

Highlights

  • Adenosquamous carcinoma (ASC) is a rare and malignant tumor of the head and neck region

  • ASC is defined by the World Health Organization as “a malignant tumor of the upper aerodigestive tract, which has two distinct squamous and glandular contingents.”

  • ASC is an aggressive tumor with a poor prognosis with frequent local and locoregional metastases despite appropriate treatment [2]

Read more

Summary

Introduction

Adenosquamous carcinoma (ASC) is a rare and malignant tumor of the head and neck region. 100 cases have been reported in the literature. This entity was first described in 1968 by Gerughty [1]. ASC is defined by the World Health Organization as “a malignant tumor of the upper aerodigestive tract, which has two distinct squamous and glandular contingents.”. It can manifest as a well differentiated or a poorly differentiated tumor, and may occur as a carcinoma in situ or an invasive tumor. ASC is an aggressive tumor with a poor prognosis with frequent local and locoregional metastases despite appropriate treatment [2]

Clinical case
Discussion
Present Absent Negative Usually absent Usually present
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call